tradingkey.logo
tradingkey.logo
Search

Alvotech SA

ALVO
Add to Watchlist
5.810USD
-0.030-0.51%
Close 09-23 16:00ET
2.27BMarket Cap
60.40P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.51%

5 Days

+13.92%

1 Month

+31.15%

6 Months

+74.47%

Year to Date

+13.26%

1 Year

-33.22%

Key Figures

5.860Open
5.890High
110.03KVolume
60.40P/E TTM
37.92P/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
5.840Prev. Close
5.700Low
636.25KTurnover
LossP/E Static
-11.87P/B
0.00%Div Yield TTM
2.06%ROA
9.04552wk High
18.82Volume Ratio
-231.86MNet Profit
390.43MShares
0.0964EPS TTM
0.22Beta
--ROE
2.94052wk Low
4.54%Amplitude
53.61%Gross Margin
2.27BMarket Cap
4.80Reward/Risk
4.90%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

Alvotech SA's Score

-0.23vs previous score
Forecast7.20
Financial Health7.11
Technical4.55
Valuation Dimensions9.00
Institutional Confidence3.00
Risk Assessment5.14

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
7.250Target Price
+24.14%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy11111111
Buy22333333
Hold11111111
Sell11111110
Strong Sell00000000

Alvotech SA Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Buy

Summary

Buy

Moving Average

Strong buy

Alvotech SA Latest Earnings Call Transcripts

Alvotech (ALVO) Q2 2026 Earnings Call: Guidance Reaffirmed

Alvotech Q2 2026 earnings call: H1 revenue fell to $212 million, FDA resubmissions advanced, and 2026 revenue and EBITDA guidance was reaffirmed.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.24/-0.03
Revenue / Forecast
105.91M/110.95M

Alvotech SA Profile

SectorBiotechnology & Medical Research
Ticker SymbolALVO
Number of employees1011
CountryLuxembourg

Ownership

ShareholdersProportion
Aztiq Pharma Partners SARL33.28%
Celtic Holdings SCA28.94%
Vanguard Capital Management, LLC1.09%
Bracebridge Capital, LLC0.87%
Shareholder TypesProportion
Corporation62.22%
Investment Advisor2.98%
Hedge Fund1.41%
Investment Advisor/Hedge Fund1.14%

FAQs

What is the current price of Alvotech SA (ALVO)?

The current price of Alvotech SA (ALVO) is 5.81.

What is the symbol of Alvotech SA?

The ticker symbol of Alvotech SA is ALVO.

What is the 52-week high of Alvotech SA?

The 52-week high of Alvotech SA is 9.04.

What is the 52-week low of Alvotech SA?

The 52-week low of Alvotech SA is 2.94.

What is the market capitalization of Alvotech SA?

The market capitalization of Alvotech SA is 2.27B.

Is Alvotech SA (ALVO) currently rated as Buy, Hold, or Sell?

According to analysts, Alvotech SA (ALVO) has an overall rating of Buy, with a price target of 7.25.

What is the Earnings Per Share (EPS TTM) of Alvotech SA (ALVO)?

The Earnings Per Share (EPS TTM) of Alvotech SA (ALVO) is 0.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.